As of our operating segments were Biological Indicators, Instruments, Continuous Monitoring and Cold Chain. Effective we renamed our Continuous Monitoring and Cold Chain operating segments to Cold Chain Monitoring and Cold Chain Packaging, respectively. In addition, we transferred certain of the Cold Chain monitoring and other services to our Cold Chain Monitoring operating segment (historically included in our Cold Chain operating segment) to align with the information being used by the chief decision maker of the Company. Accordingly, all prior year segment information presented herein has been adjusted to reflect this change in our organizational structure. The following tables set forth our segment information (in thousands):

 

Reconciling items include general and administrative, research and development, and other expenses.

 

Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):

 

foreign country exceeds percent of total revenues.

 

All long-lived assets are located in the United States except for and which are associated with our French and Canadian subsidiaries, respectively.